TFIIH is a candidate for mediating transcription activathe XPD mutation alters cdk7 function in RAR␣ phostion because it possesses most of the enzymatic activiphorylation. Transactivation is restored upon overexties that are essential for RNA synthesis. This multipropression of either the wild-type XPD or the RAR␣S77E tein complex, also involved in the nucleotide excision (a mutation which mimics phosphorylated RAR␣).
carcinogenesis, including melanomas, squamous cell
We then tested the transactivation capacity of the carcinomas, and basal cell carcinomas (Kraemer et al., estrogen (ER␣) and the androgen (AR; Lee et al., 2000) 1988). They also exhibit a large spectrum of clinical abnuclear receptors by using pERE-Luc ( Figure 1A ) and normalities such as mental retardation, immature sexual pARE-CAT reporters (cf. Experimental Procedures). In condevelopment, skeletal abnormalities, and dwarfism (de trast to RAR␣, ER␣, and AR are not expressed endogeBoer and Hoeijmakers, 2000), some of which could be nously in HeLa and HD2 cells. We thus cotransfected connected with hormonal dysfunctions. Moreover, retiboth cell lines with either the pERE-Luc or pARE-CAT noic acid, already used as a chemopreventive agent for reporter and either of the expression vector pcDNAthe treatment of several types of cancer (reviewed in ER␣, pSV-ARo, or the corresponding empty vectors, and Niles, 2000), was rather successful to decrease carcinopCH110. Both receptors were similarly overexpressed in genesis susceptibility in XP patients (Kraemer et al.,
HeLa and HD2 cells as shown by Western blotting (Fig-1988) .
ures 1C and 1D, upper panels). Cells were subsequently In the present study, we demonstrate that mutations treated with 10 Ϫ8 M of either 17␤-estradiol (E2) or 5␣-in the xpd gene result in a drop in the ability of nuclear dihydrotestosterone (DHT). In HeLa cells, reporter gene receptors to be phosphorylated by TFIIH and to stimuactivities were stimulated by ER␣ (10-fold) and AR (50-late expression of the target genes. We show that this fold), respectively, upon addition of their corresponding defect can be circumvented upon overexpression of ligands ( Figures 1C and 1D , dark boxes). In contrast, either the wild-type XPD or the RAR␣S77E form of RAR␣, transactivation observed in HD2 cells was 4-5-fold lower in which the glutamic acid mimics a phosphorylated than in HeLa cells (hatched boxes). Control experiments serine residue. Together, our data strongly enlighten show the specificity of the reporter gene activation, the key role of TFIIH in the transcriptional activation which requires the presence of both the nuclear receptor mediated by hormonal receptors and illustrate how and its cognate ligand. Finally, we also tested the ability some phenotypes of XPD patients could find explanaof the chimeric protein Gal4-VP16 (GVP16) to mediate tion in a defect of one of the other enzymatic functions transcription activation in HD2 cells. HeLa and HD2 cells of this complex.
were cotransfected by the reporter construct pGal-Luc, in which four Gal4 binding sites control expression of Results the Luc gene, the eukaryotic expression vector pSG5-GVP16, or the corresponding empty vector. In both cells, XPD Mutation Prevents Nuclear Receptor-GVP16 significantly stimulates expression of the reMediated Activation of Transcription porter gene ( Figure 1E ), demonstrating that the tranBecause mutations in the XPD subunit of TFIIH can lead scriptional regulation defect in HD2 cells is restricted to to pathologies with complex phenotypes, some of which certain activators. cannot be explained on the basis of NER defects alone, Altogether, these data highlight a reduced ligandwe wondered if such mutation(s) could alter expression dependent activation of transcription by three nuclear of genes that are under the control of nuclear receptor receptors, RAR␣, ER␣, and AR, in cells bearing a mutaresponse elements. We thus monitored ligand-depention in the XPD subunit of the basal transcription/repair dent activation of a reporter gene in the HD2 cell line factor TFIIH. They also suggest that regulation of the that carries the point mutation R683W in XPD. expression of hormone-responsive genes so far tested A DR5-type retinoic acid response element (RARE), involves a common mechanism that is not related to specifically recognized by RAR/RXR heterodimers (Dilsome cellular specialization but that rather depends on worth et al., 2000), was cloned in front of the luciferase the integrity of TFIIH. reporter gene resulting in the pRARE-Luc reporter construct ( Figure 1A ). Since HD2 cells result from the hybridDefect in Transactivation Is Circumvented ization between human fibroblasts (carring the mutation upon wtXPD Overexpression in the xpd gene) and HeLa cells (Johnson et al., 1985) , the We then wondered whether the defect in transactivation cellular response to retinoic acid (t-RA) was monitored in by the nuclear receptors observed in HD2 cells, was HD2 cells and HeLa cells, as well as in wild-type MRC5 due to the mutation in the xpd gene itself. HD2 and HeLa fibroblasts. HD2, HeLa, and MRC5 cells, which contain cells were thus cotransfected by either pRARE-Luc or equivalent amounts of endogenous RAR␣, RXR␣, and pARE-CAT in addition to either pcDNA-XPD, encoding TFIIH proteins, as established by immunoblotting on the wild-type XPD (wtXPD), or the corresponding empty crude cell extracts ( Figure 1B, left Figure 1B , dark and clear boxes), where lanes 2 to lanes 1). This correction was specific to the after increasing the t-RA concentration inhibits tranwtXPD protein since neither cotransfection with the scription activation. In contrast, the t-RA response obsame amount of the corresponding empty vector (lanes served in the HD2 cells is about half of that observed in the two wild-type cell lines ( Figure 1B, hatched boxes) .
3) nor overexpression of two unrelated proteins (p53 and these observations allow us to extrapolate the conclucontains all nine subunits in "physiological" conditions, the mutation in XPD weakens anchoring of the kinase sion that the defect of transcription activation observed in vivo is not linked to the basal transcription activity (CAK) subcomplex to the core-TFIIH. Knowing that the cdk7 kinase phosphorylates nuclear of HD2-TFIIH but, rather, to a distinct function of the complex in the transcription process. receptors in vitro, we then questioned whether the XPD mutation might alter this process. We therefore investigated the in vivo phosphorylation state of RAR␣ in XPD-
XPD Mutation Is Responsible for RAR␣ deficient cells. Substantial amounts of HeLa or HD2 cells Underphosphorylation in HD2 Cells
were incubated with radiolabeled orthophosphate and, We then wondered whether the R683W mutation could after concentration adjustment by Western blotting, imaffect the integrity of the TFIIH complex. Indeed, previmunoprecipitated RAR␣ fraction from both extracts ous studies have shown that the XPD subunit anchors were subjected to autoradiography ( Figure 4A ). We obthe CAK subcomplex to the core-TFIIH (Drapkin et al., served that RAR␣ extracted from HD2 cells is signifi-1996; Reardon et al., 1996; Coin et al., 1999). Moreover, cantly underphosphorylated (around 50%) compared to mutations in the carboxy-terminal end of XPD weaken that from HeLa cells. We then wondered whether in vivo its binding to the p44 subunit of the core-TFIIH (Coin et underphosphorylation of RAR␣ was due to a lack of al., 1998). TFIIH complexes were thus immunopurified phosphorylation by the kinase of TFIIH. We thus tested from HeLa or HD2 cells at either low-salt (50 mM KCl) the ability of HD2-TFIIH, immunopurified at low-salt conor high-salt (400 mM KCl) concentration. When immunocentration ( Figure 3B , lane 2), to phosphorylate in vitro purification was performed at high stringency, we oba bacterially expressed RAR␣ on its serine 77, a site of served that the XPD and the CAK subunits unhooked phosphorylation that is crucial for the transactivating from other TFIIH subunits in HD2 cells whereas HeLaactivity of RAR␣ (Rochette-Egly et al., 1997). Using a TFIIH was intact ( Figure 3B, compare lanes 2 and 4) These results demonstrate that overexpression of the "constitutively" phosphorylated RAR␣ (RAR␣S77E) substitutes for the defect resulting from the XPD mutation in HD2 cells. In addition, they provide evidence that the defect in ligand-dependent activation is most likely due to the inability of the cdk7 kinase to efficiently phosphorylate RAR␣ on its S77 residue. Although we did not associate the helicase function of XPD with a transcription defect of TFIIH, we show here how XPD provides support for CAK action and, as such, plays an important structural function. We demonstrate that TFIIH is an indispensable component of the hormonal response in vivo through its cdk7 subunit that phosphorylates nuclear receptors, allowing further transactivation of their target genes.
RA-Transactivation Deficiency Is Not Restricted to the R683W Mutation in XPD

Hormone-Mediated Regulation of Transcription Requires Intact TFIIH
When transfected in cells carring a mutation in the XPD subunit of TFIIH, expression of the reporter genes placed under the control of RAR␣, ER␣, and AR is affected, whereas Gal4-VP16 activation occurs normally. One can imagine that the stronger magnitude of transactivation alteration by the exogenous receptors ER␣ The present data suggest that nuclear receptor phosphorylation might occur during the formation of the prephorylation by the kinase of TFIIH in the hormonal response. Since XPD bridges CAK to the core-TFIIH, the initiation complex, at the time when TFIIH and the nu- 
